230 related articles for article (PubMed ID: 7874894)
1. Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents.
Murray MJ; Coursin DB; Scuderi PE; Kamath G; Prough DS; Howard DM; Abou-Donia MA
Crit Care Med; 1995 Mar; 23(3):450-8. PubMed ID: 7874894
[TBL] [Abstract][Full Text] [Related]
2. Paralysis in the critically ill: intermittent bolus pancuronium compared with continuous infusion.
de Lemos JM; Carr RR; Shalansky KF; Bevan DR; Ronco JJ
Crit Care Med; 1999 Dec; 27(12):2648-55. PubMed ID: 10628604
[TBL] [Abstract][Full Text] [Related]
3. Dose response, recovery, and cost of doxacurium as a continuous infusion in neurosurgical intensive care unit patients.
Prielipp RC; Robinson JC; Wilson JA; MacGregor DA; Scuderi PE
Crit Care Med; 1997 Jul; 25(7):1236-41. PubMed ID: 9233753
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and pharmacodynamic comparison of doxacurium and pipecuronium with pancuronium during induction of cardiac anesthesia: does the benefit justify the cost?
Rathmell JP; Brooker RF; Prielipp RC; Butterworth JF; Gravlee GP
Anesth Analg; 1993 Mar; 76(3):513-9. PubMed ID: 8383933
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant.
Basta SJ; Savarese JJ; Ali HH; Embree PB; Schwartz AF; Rudd GD; Wastila WB
Anesthesiology; 1988 Oct; 69(4):478-86. PubMed ID: 2972233
[TBL] [Abstract][Full Text] [Related]
6. The neuromuscular blocking and cardiovascular effects of doxacurium chloride in patients receiving nitrous oxide narcotic anesthesia.
Murray DJ; Mehta MP; Choi WW; Forbes RB; Sokoll MD; Gergis SD; Rudd GD; Abou-Donia MM
Anesthesiology; 1988 Oct; 69(4):472-7. PubMed ID: 3177909
[TBL] [Abstract][Full Text] [Related]
7. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients.
Rudis MI; Sikora CA; Angus E; Peterson E; Popovich J; Hyzy R; Zarowitz BJ
Crit Care Med; 1997 Apr; 25(4):575-83. PubMed ID: 9142020
[TBL] [Abstract][Full Text] [Related]
8. Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children.
Bevan JC; Purday JP; Reimer EJ; Bevan DR
Can J Anaesth; 1994 Nov; 41(11):1074-80. PubMed ID: 7828255
[TBL] [Abstract][Full Text] [Related]
9. Train-of-four recovery after pharmacologic antagonism of pancuronium-, pipecuronium-, and doxacurium-induced neuromuscular block in anaesthetized humans.
Stinson LW; Lanier WL; Lennon RL
Acta Anaesthesiol Scand; 1995 Apr; 39(3):406-10. PubMed ID: 7793225
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of doxacurium, pancuronium and vecuronium in anaesthetized patients presenting for coronary artery bypass surgery.
Emmott RS; Bracey BJ; Goldhill DR; Yate PM; Flynn PJ
Br J Anaesth; 1990 Oct; 65(4):480-6. PubMed ID: 1979009
[TBL] [Abstract][Full Text] [Related]
11. Comparison of neuromuscular, cardiovascular, and histamine-releasing properties of doxacurium and pipecuronium.
Denman WT; Goudsouzian NG; Gelb C
J Clin Anesth; 1996 Mar; 8(2):113-8. PubMed ID: 8695092
[TBL] [Abstract][Full Text] [Related]
12. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients.
Newman PJ; Quinn AC; Grounds RM; Hunter JM; Boyd AH; Eastwood NB; Pollard BJ; Pearson AJ; Harper NJ; Beale RJ; Sutjarittam M; Elliot JM; Bion JF
Crit Care Med; 1997 Jul; 25(7):1139-42. PubMed ID: 9233738
[TBL] [Abstract][Full Text] [Related]
13. Neuromuscular effects of doxacurium chloride in isoflurane-anesthetized dogs.
Martinez EA; Wooldridge AA; Hartsfield SM; Mealey KL
Vet Surg; 1998; 27(3):279-83. PubMed ID: 9605239
[TBL] [Abstract][Full Text] [Related]
14. Long-acting nondepolarizing neuromuscular blocking agents.
Embree PB
AANA J; 1993 Aug; 61(4):382-7. PubMed ID: 8397465
[TBL] [Abstract][Full Text] [Related]
15. Doxacurium. A review of its pharmacology and clinical potential in anaesthesia.
Faulds D; Clissold SP
Drugs; 1991 Oct; 42(4):673-89. PubMed ID: 1723368
[TBL] [Abstract][Full Text] [Related]
16. Postanesthesia care unit recovery times and neuromuscular blocking drugs: a prospective study of orthopedic surgical patients randomized to receive pancuronium or rocuronium.
Murphy GS; Szokol JW; Franklin M; Marymont JH; Avram MJ; Vender JS
Anesth Analg; 2004 Jan; 98(1):193-200. PubMed ID: 14693617
[TBL] [Abstract][Full Text] [Related]
17. Mivacurium when preceded by pancuronium becomes a long-acting muscle relaxant.
Erkola O; Rautoma P; Meretoja OA
Anesthesiology; 1996 Mar; 84(3):562-5. PubMed ID: 8659784
[TBL] [Abstract][Full Text] [Related]
18. Neuromuscular and cardiovascular effects of doxacurium in children anaesthetized with halothane.
Goudsouzian NG; Alifimoff JK; Liu LM; Foster V; McNulty B; Savarese JJ
Br J Anaesth; 1989 Mar; 62(3):263-8. PubMed ID: 2522789
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacodynamics and clinical adverse effects of mivacurium. The effect of oral premedication with H1/H2 antagonists].
Mayer M; Doenicke A; Nebauer AE; Rosenberger C; Lorenz W; Peter K
Anaesthesist; 1993 Sep; 42(9):592-6. PubMed ID: 8105716
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of doxacurium during cardiac surgery with hypothermic cardiopulmonary bypass.
McDonagh P; Dupuis JY; Curran M; Kitts J; Wynands JE
Can J Anaesth; 1996 Feb; 43(2):134-40. PubMed ID: 8825538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
